Author

Ahmad S. Altiti

Feinstein Institute for Medical ResearchORCID 0000-0003-2946-4477Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Ajit K ParhiiD· 1 shared Ankur GargiD· 1 shared Camila Gonzalez· 1 shared Christy Felice· 1 shared Darryl PappiniD· 1 shared Elad ElkayamiD· 1 shared Evdokia MichalopoulouiD· 1 shared Jesús D. Rosado-Lugo· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Ajit K ParhiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 5, 2025

Novel small-molecule inhibitors of the protein kinase DYRK: Potential Therapeutic candidates in cancer

Prabhadevi Venkataramani, Elad Elkayam, Ankur Garg…·Nicholas K. Tonks

This study identifies two selective DYRK1A inhibitors, FC-2 and FC-3, which show antitumor effects in glioblastoma models.

DOI 10.1101/2025.11.05.686653

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintFeb 28, 2025

TXA11114: Discovery of an in vivo efficacious efflux pump inhibitor in Pseudomonas aeruginosa

Jesús D. Rosado-Lugo, Pratik Datta, Ahmad S. Altiti…·Ajit K Parhi

This paper describes the discovery of TXA11114, an efflux pump inhibitor that enhances levofloxacin efficacy against multidrug-resistant Pseudomonas aeruginosa in vivo with a safe toxicology profile.

1 citation

mouseexperimental assay

𝕏 PostBluesky